A Dynamic Leader Leveraging AI in Pharmaceutical Industry

As a former engineer and data scientist in the pharmaceutical industry, Taylor became very familiar with the challenges the sector faces to maintain product quality.  She said she lived through the pain points and gained deep computational experience to alleviate the pains of quality control.  In this capacity, Taylor recognized the significant potential for AI in process development and commercial drug manufacturing.  However, pharmaceutical companies are not software companies, so she started her own AI software company, Modicus Prime, to provide pharma with the proper AI computational techniques and vigorously apply them to help safely and more efficiently produce drugs for patients.

Providing Intelligent Image Analysis of Biologics

Modicus Prime's Self-Service AI software places cutting-edge AI where it belongs: in the hands of Life Sciences domain experts. The result is real-time AI processing of any image data – from biologic morphology analysis to commercial contamination detection – without data scientists.  The firm's computer vision solution, mpVision, provides intelligent image analysis to monitor biologics at any scale.  mpVision has been tested by scientists in a top 10 Pharma company and supports their mission to eliminate contamination from the pharmaceutical industry.  These contaminations cost 100's of millions of dollars per incident, as illustrated by the recent Covid vaccine 60 M incident experienced by J&J/AstraZeneca/Emergent. Such unmet needs of the Life Sciences industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs, are being met with Modicus Prime's Self-Service AI solutions.

Meeting the Unmet Demands of Pharma's Qualities

On average, in the pharmaceutical industry, there is 1 product quality control failure per year, with contamination being the root cause at the commercial level, Taylor explains. Recent and very public examples of such contaminations cost 100s of millions of dollars per incident, as illustrated by the 60 million COVID-19 vaccine dose incidents experienced by J&J/AstraZeneca/Emergent.  Moderna's COVID-19 vaccine contamination in Japan shocked the public yet again, she continued.
 
Unfortunately, such occurrences are familiar horror stories reported by the FDA and its fellow regulatory bodies.  Batch processing costs the pharmaceutical manufacturing industry approximately $50 billion yearly due to contaminations and expenses accompanying product recalls.
 
These examples underline the problem the firm is currently addressing within the pharmaceutical industry: their need for sufficient quality control across the pharmaceutical value chain.

Maximizing Resources and Reducing Operating Costs

Contaminations of drug products result in fatalities, and protecting the general public from such health hazards underlines their mission with Modicus Prime.  Modicus Prime's computer vision software automates biologics image analysis and is designed to solve the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing.

Burgeoning through Challenges

Taylor says she is most interested in deep-tech applications for gene & cell therapies, personalized medicine, and drug discovery solutions. Many unmet needs, especially in the orphan drug space, can be immediately addressed with AI technologies.  The regulatory bodies, including the FDA, are working diligently with industry experts to write guidelines around AI applications and their successful implementation in the pharmaceutical industry, which is a substantial technical challenge. Until good health is an inalienable right, we must push technology to the brink of what is impossible to ensure a sustainable future for humanity, she concludes.

Treasured Partnerships

Modicus Prime is venture-backed and has strategic partnerships with many large corporations, including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), eLabNext (Eppendorf), Dotmatics, and PlugandPlay.

Management: Taylor Chartier, CEO, and Founder

Website: https://www.modicusprime.com/